Matinas BioPharma (MTNB) Q3 2024 Earnings
MTNB·Reported November 13, 2024·Before market open
Diluted EPS came in at $-0.85, beat the $-1.05 consensus by $0.20.
Diluted EPS
$-0.85beat by $0.20
Consensus: $-1.05
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Matinas BioPharma's Q3 2024 earnings report.
Matinas BioPharma (MTNB) reported Q3 2024 earnings on November 13, 2024 before market open.
Matinas BioPharma reported diluted EPS of $-0.85 for Q3 2024.
EPS beat the consensus estimate of $-1.05 by $0.20.
You can read the 10-Q periodic report (0001493152-24-045201) directly on SEC EDGAR. The filing index links above go to sec.gov.